Sexually Transmitted Diseases (STD) Diagnostics Market - Global Industry Analysis

Sexually Transmitted Diseases (STD) Diagnostics Market

Sexually Transmitted Diseases (STD) Diagnostics Market Statistics 2028

Category: Healthcare Report Format : PDF Pages: 184 Report Code: ZMR-558 Published Date: Mar-2022 Status : Published

Sexually Transmitted Diseases (STD) Dia Market

Table Of Content

Methodology

Free Analysis

The term sexually transmitted diseases or STD are commonly used to refer to clinical syndromes and infectious diseases caused by pathogens that can be acquired and transmitted through sexual activity. These infections can easily spread by vaginal or anal intercourse, and sometimes by oral sex. STDs can also spread from the blood of infected patients. In addition, pregnant women with STD’s may pass their infection to infants in the uterus (womb), during birth, or through breast-feeding. Prevention of STD infection is possible by having protective sex (using condoms) or abstaining from the sex.

Globally, STD diagnostics market has been accelerated by the rise in the percentage of unprotected sex which leads to increase in the prevalence of sexually transmitted diseases. Furthermore, lack of awareness coupled with unprotected sex is considered as major governing factors which promote the cause of sexually transmitted diseases and thus STD diagnostic market. Moreover, many lifestyle-related factors, such as having multiple sex partners are estimated to drive the sexual transmitted diseases diagnostic market. However, lack of education, psychological impact and the unwillingness of the infected population to undergo prognosis is expected to hinder the growth of the market. In addition, prevention of infection by vaccination is major restraining factor in a growth of STDs diagnostic market.

Based on the type, the global market of STD diagnostic test is bifurcated into seven types: chlamydia testing, syphilis testing, gonorrhea testing, herpes simplex virus testing, human papiloma virus testing, human immunodeficiency virus testing and others. Global HIV diagnostics market size was approximately USD 2.77 billion in 2019, with a CAGR of 9.5% during the forecast period. The PAP smear tests segment accounted for the largest share of approximately more than 50% of the total HPV testing market in 2019. Factors attributed to its growth due to its lower test prices and growing awareness about the cancer diagnosis. Similarly, the HPV testing market is forecast to grow at the fastest growth rate within the forecast period.

Based on end-user, the global market for STD diagnostic test is bifurcated into two types: hospital and others. In end-user segment, the hospital was the leading segment in 2019 and this segment will remain in continuous growth during the forecast period due to the continuous rise in HPV virus across the globe.

Based on the testing device, the global market for STD diagnostic test is segmented into two major types: laboratory testing device and point of care device. The laboratory testing device market is further sub-segmented into thermal cyclers - PCR, lateral flow readers – immunochromatographic assays, flow cytometers, differential light scattering machines, absorbance microplate reader - Enzyme Linked Immunosorbent Assay (ELISA) and others

Based on geographies, the global market for STD diagnostic is bifurcated into five types: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. These segments are further bifurcated into the U.S., UK, Germany, France, China, Japan, India, and Brazil. North America accounted for the largest share of the global STD diagnostic market followed by Europe. This growth is attributed due to rising awareness related to health care in this region. Moreover, STD diagnostics market has the huge opportunity in the emerging markets of Asia Pacific due to increasing standard of living, large patient base in this region. However, the Asia-Pacific market is projected to grow at the highest CAGR during the forecast period, due to the rising incidence of sexually transmitted diseases, increasing government support, and growing upper middle-class population and rise in disposable income levels in this region.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global STD diagnostics market include Roche Holdings AG, Abbott Laboratories, Becton Dickinson and Company, Hologic Inc., Danaher Corporation, Affymetrix, bioMerieux, Cepheid Inc., Alere Inc., DiaSorin, and Orasure.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed